ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Edward D. Verrier
Michael S. Mulligan
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farivar, A. S.
Right arrow Articles by Mulligan, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farivar, A. S.
Right arrow Articles by Mulligan, M. S.
Related Collections
Right arrow Lung - transplantation

Ann Thorac Surg 2006;81:1061-1067
© 2006 The Society of Thoracic Surgeons

Original article: General thoracic

Crosstalk Between Thrombosis and Inflammation in Lung Reperfusion Injury

Alexander S. Farivar, MD * , Mauricio F. Delgado, MD, Anton S. McCourtie, MRCS, Andrew D. Barnes, PharmD, Edward D. Verrier, MD, Michael S. Mulligan, MD

Division of Cardiothoracic Surgery, University of Washington Medical Center, Seattle, Washington

Accepted for publication September 15, 2005.

* Address correspondence to Dr Farivar, University of Washington Medical Center, 1959 NE Pacific St, Division of Cardiothoracic Surgery, Box 356310, Seattle, WA 98195 (Email: afarivar{at}u.washington.edu).

BACKGROUND: Activation of extravascular coagulation has been reported in acute lung injury models of sepsis and acute respiratory distress syndrome. Thrombin, the main effector protease of extravascular coagulation, activates proinflammatory cell types, including macrophages, endothelial cells, and neutrophils, each of which participates in lung ischemia–reperfusion injury. We used hirudin, a potent, specific direct thrombin inhibitor, to define the role of thrombin in lung ischemia–reperfusion injury.

METHODS: Rats were pretreated with hirudin 30 minutes before warm, in situ left lung ischemia and reperfusion. Multiple in vivo assessments of lung injury were determined, and mechanistic studies assessed transcriptional regulation early in reperfusion and proinflammatory protein secretion late in reperfusion. Immunohistochemistry localized thrombin activation.

RESULTS: Thrombin localized to macrophages and endothelial and epithelial cells early in reperfusion. Hirudin significantly limited lung ischemia–reperfusion injury–induced derangements in vascular permeability and intraalveolar inflammatory cell sequestration, resulting in improved arterial oxygenation after ischemia and 4 hours of reperfusion. The protection was transcriptionally mediated by attenuated activator protein-1 and early growth response-1 transactivation, but not nuclear factor kappa B transactivation. This was associated with reduced chemokine, but not tumor necrosis factor {alpha}, secretion late in reperfusion.

CONCLUSIONS: Thrombin promotes lung ischemia–reperfusion injury, as hirudin protected against experimental acute lung injury. Hirudin conferred protection through a mechanism independent of nuclear factor kappa B and tumor necrosis factor {alpha}, suggesting that its effects may be mediated by a parallel, synergistic inflammatory pathway through activator protein-1 and early growth response-1.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
B.-S. Ding, N. Hong, M. Christofidou-Solomidou, C. Gottstein, S. M. Albelda, D. B. Cines, A. B. Fisher, and V. R. Muzykantov
Anchoring Fusion Thrombomodulin to the Endothelial Lumen Protects against Injury-induced Lung Thrombosis and Inflammation
Am. J. Respir. Crit. Care Med., August 1, 2009; 180(3): 247 - 256.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
C. L. Lau, Y. Zhao, J. Kim, I. L. Kron, A. Sharma, Z. Yang, V. E. Laubach, J. Linden, G. Ailawadi, and D. J. Pinsky
Enhanced fibrinolysis protects against lung ischemia-reperfusion injury.
J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1241 - 1248.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. S. Wolf, H. E. Merry, A. S. Farivar, A. S. McCourtie, and M. S. Mulligan
Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury
J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 656 - 665.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.